News

uMotif has been recognised in the Global Digital Health 100 for second year running. The Global Digital Health 100 is one of the HealthTech industries foremost technology award programmes, celebrating innovation and entrepreneurship. It recognises and supports health technology companies that are demonstrating the greatest potential to change the way that healthcare is delivered. Companies are analysed and selected based on their ability to demonstrate true innovation and the opportunity to disrupt the delivery of healthcare at scale.

Read…

AVORA, the enterprise analytics platform powered by native machine learning technology, today announced it has raised $6.5m (£5.1m) in a Series A funding round led by Albion VC and existing investor Crane. AVORA has already built an impressive client base, including Telefonica, OMD, NPR, HBO LatAm and Ocado. The UK start-up will use the funds raised to expand its leadership and sales teams, launch in the US market and continue to evolve its technology by enhancing its in-platform machine learning algorithms. The financing will also pave the way for…

Spinout marks the first of UCLTF’s early stage investments to file for IPO.

Orchard Therapeutics, a biotechnology company dedicated to transforming the lives of patients with rare disorders through innovative gene therapies, has today announced closing of its initial public offering of 16,103,572 American Depositary Shares, each representing an ordinary share at an initial public offering price of $14.00 per share. The gross proceeds from the offering were $225.5 million before deducting underwriting commissions and estimated offering…

Global private equity firm specialising in high-growth companies invests in Egress to accelerate global expansion.

Egress, a leading provider of data privacy and compliance services designed to secure unstructured data, today announced it has raised $40 million in a Series C financing round from FTV Capital, with continued participation from existing backer AlbionVC. Egress will use this investment to build on its ongoing rapid growth in Europe and North America, as well as accelerate development of new technology across its data security…

AlbionVC and Ananda Ventures have led a £3m fundraising round in Raremark, the leading patient-data platform in rare disease. Oltre Venture and, existing major investor, the Cass Entrepreneurship Fund also invested. 

The funding will be used to develop Raremark’s patient-engagement and data-analysis technology, helping biopharmaceutical companies to identify, engage and learn from patients, accelerating the development of new treatments.

Raremark’s platform is the foundation for building research networks of rare disease patients and…

Hazy has been listed by Forbes as one of the Top 15 European Machine Learning companies to watch. Hazy is an AI spin-out from UCL and is one of the businesses invested in by the UCL Technology Fund which is managed by Albion in collaboration with UCLB.

www.forbes.com/15-machine-learning-companies-to-watch-in-europe

Albion is delighted to have been awarded the Investor Allstars 2018  - VCT of The Year Award.

The judges looked for a track record of fundraising between April 2017 – April 2018 An impressive level of investment and exits achieved during the period A reputation for providing valuable strategic and commercial advice to portfolio companies A strong financial return for private investors

 

Arecor, the UK-based biopharmaceutical formulation company, has raised £6 million from new and existing investors to develop groundbreaking pharmaceutical drugs to transform the treatment of diabetes. The fundraising was led by Calculus Capital, Albion Capital, and Downing Ventures.  BioScience Managers Limited, the international healthcare investment firm, advised Downing Ventures.Through the application of its technology platform, Arecor is creating faster working, more effective drugs that help progress the creation of the next generation of…